moxifloxacin has been researched along with fusidic acid in 7 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 1,742 | 117 | 344 |
Protein | Taxonomy | moxifloxacin (IC50) | fusidic acid (IC50) |
---|---|---|---|
large T antigen | Betapolyomavirus macacae | 20.42 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Denis, O; Nguyen, HA; Struelens, MJ; Theunis, A; Tulkens, PM; Van Bambeke, F; Vergison, A | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Gottlieb, T; Leroi, MJ; Siarakas, S | 1 |
Kamel, AG; Lim, VK; Norazah, A; Rohani, MY | 1 |
Carrer, DP; Giamarellou, H; Kanellakopoulou, K; Panagopoulos, P; Papadopoulos, A; Plachouras, D; Tsaganos, T | 1 |
Fernandes, P; Rodriguez-Villalobos, H; Siala, W; Tulkens, PM; Van Bambeke, F | 1 |
7 other study(ies) available for moxifloxacin and fusidic acid
Article | Year |
---|---|
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Dose-Response Relationship, Drug; Fusidic Acid; Gentamicins; Humans; Macrophages; Microbial Sensitivity Tests; Oxacillin; Phenotype; Protein Binding; Staphylococcus aureus; Thymidine | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
Topics: Acetamides; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fluoroquinolones; Fusidic Acid; Gatifloxacin; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Quinolines; Sensitivity and Specificity; Vancomycin | 2002 |
In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
Topics: Anti-Bacterial Agents; Aza Compounds; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Fusidic Acid; Humans; In Vitro Techniques; Levofloxacin; Malaysia; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Rifampin; Staphylococcus aureus; Virginiamycin | 2005 |
In vitro elution of moxifloxacin and fusidic acid by a synthetic crystallic semihydrate form of calcium sulphate (Stimulan).
Topics: Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Biocompatible Materials; Bone Substitutes; Calcium Sulfate; Chromatography, High Pressure Liquid; Drug Delivery Systems; Fluoroquinolones; Fusidic Acid; Moxifloxacin; Quinolines; Spectrophotometry, Ultraviolet | 2008 |
Activities of Combinations of Antistaphylococcal Antibiotics with Fusidic Acid against Staphylococcal Biofilms in
Topics: Anti-Bacterial Agents; Biofilms; Daptomycin; Fusidic Acid; Humans; Microbial Sensitivity Tests; Moxifloxacin; Rifampin; Staphylococcus epidermidis | 2018 |